Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

<< Previous

Bullboard Posts

Next >>

Post by mrwestcoaston May 04, 2020 6:51pm

351 Views

Post# 30985691

Nostalgic feeling

Been buying a lot of psychedelic start-ups in the last two days. Feels a lot like the early pot industry. Either no know cares or people just aren't aware. Good exposure coming though. I hope they talk about companies and the medical side of it. Have a Good Trip: Adventures in Psychedelics (Netflix Documentary) coming out May 11th.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China